<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01935414</url>
  </required_header>
  <id_info>
    <org_study_id>FKD-TEDS-001</org_study_id>
    <nct_id>NCT01935414</nct_id>
  </id_info>
  <brief_title>Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study</brief_title>
  <official_title>A Multicentre Randomised Controlled Trial Comparing the Incidence of Asymptomatic and Symptomatic Deep Vein Thrombosis Between the gekoTM Device and Thromboembolism Deterrent Stockings in Patients Recovering From Total Hip Replacement Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Firstkind Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Firstkind Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study hypothesises that the geko™ device is more efficient than TEDS in preventing the
      formation of symptomatic/asymptomatic Deep Vein Thrombosis (DVTs), post-surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of asymptomatic DVT assessed by Duplex Ultrasound</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Deep Vein Thrombosis</condition>
  <arm_group>
    <arm_group_label>geko™</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>geko™ use continually post-surgery for 48hrs and then a minimum of 4hrs/day until discharge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TEDS stockings</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TEDS use continually post-surgery for 48hrs and then a minimum of 4hrs/day until discharge</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>geko™ post-surgery for 48hrs then 4hrs/day until discharge.</intervention_name>
    <arm_group_label>geko™</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TEDS post-surgery for 48hrs then 4hrs/day until discharge.</intervention_name>
    <arm_group_label>TEDS stockings</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 18 years of age and over

          2. Free of significant abnormal findings as determined by medical history (specifically
             an absence of DVT or haematological disorders).

          3. Has not used any medications (prescribed or over-the-counter including herbal
             remedies) judged to be significant by the Principal Investigator during the ten (10)
             days preceding enrolment.

          4. Able to understand the Patient Information Sheet and willing to sign the written
             Informed Consent Form.

          5. Able and willing to follow the protocol requirements.

        Exclusion Criteria:

          1. Are requiring hip revision surgery

          2. History or signs of previous deep or superficial vein thrombosis/pulmonary embolism.

          3. Evidence of asymptomatic DVT by Duplex Ultrasound

          4. Peripheral arterial disease (ABPI &lt; 0.8), varicose veins or lower limb ulceration or
             ischemia.

          5. Significant varicose veins, phlebitis or lower limb ulceration or ischemia. CEAP Grade
             4-6. See Appendix 2

          6. Recent surgery within the last 3 months (such as abdominal, gynaecological, hip or
             knee replacement).

          7. Recent trauma to lower limb.

          8. Chronic Obesity (BMI Index &gt;40kg/m2).

          9. Pregnancy.

         10. Significant history of following diseases I. Cardiovascular: Recent MI (&lt; 6 months)
             II. Percutaneous Coronary Intervention (PCI) with stent (&lt; 3 months for Bare Metal
             Stent (BMS) and &lt; 12 months for Drug Eluding Stent (DES) III. Moderate to severe CCF,
             uncontrolled AF IV. Neurological: Stroke, Hemiplegia/Paraplegia, Myopathies V.
             Significant dermatological conditions affecting lower limbs resulting in broken or
             inflamed skin particularly at the site where the device is to be fitted.

             VI. Clinically significant haematological conditions i.e. coagulation disorders,
             sickle cell disease VII. Psychiatric disorders

         11. On LMWH/Heparin (Prophylactic/therapeutic doses) or Warfarin or warfarin stopped
             recently and replaced by LMWH/ Heparin

         12. Long term steroid with dermatological changes

         13. A pulse rate of less than 40 beats/minute

         14. A sitting systolic blood pressure &gt;180 and &lt;100 mmHg and/or a sitting diastolic
             pressure of &gt;100 mmHg.

         15. Any significant illness during the four (4) weeks preceding the hip replacement
             surgery.

         16. Participation in any clinical study during the eight (8) weeks preceding the screening
             period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Matthew Womack, PhD</last_name>
    <phone>+44(0) 7456427910</phone>
    <email>matthew.womack@firstkindmedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>BMI The Harbour Hospital</name>
      <address>
        <city>Poole</city>
        <state>Dorset</state>
        <zip>BH15 2BH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.gekodevices.com/en-uk/</url>
    <description>Company website</description>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2013</study_first_submitted>
  <study_first_submitted_qc>August 30, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 5, 2013</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

